Lacosamida Farmoz

Lacosamide, the active ingredient in Lacosamida Farmoz, is an anticonvulsant presented as an oral tablet for oral use. It works by stabilizing neuronal membranes and is indicated for the treatment of partial‑onset seizures in patients with epilepsy, including those who have not responded adequately to other therapies.

GNH USA supplies Lacosamida Farmoz as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, ensuring quality and regulatory compliance across markets.

Lacosamide is an anticonvulsant that targets focal seizure activity. - Partial‑onset seizures: reduces seizure frequency as monotherapy or adjunct therapy. - Focal epilepsy: provides seizure control in patients with focal onset seizures. - Adjunctive therapy for refractory focal seizures: used when other antiepileptic drugs are insufficient.

Lacosamide may cause a range of adverse reactions.

Common Side Effects: - Dizziness: sensation of light‑headedness or unsteadiness. - Headache: mild to moderate pain in the head region. - Nausea: feeling of queasiness, sometimes with vomiting. - Fatigue: unusual tiredness or lack of energy. - Blurred vision: temporary visual disturbances. - Somnolence: increased sleepiness during the day.

Serious or Rare Side Effects: - Cardiac conduction abnormalities: PR interval prolongation or arrhythmia. - Severe skin reactions: Stevens‑Johnson syndrome or toxic epidermal necrolysis. - Suicidal ideation: emergence of thoughts of self‑harm. - Hypersensitivity reactions: rash, angioedema, or anaphylaxis. - Liver enzyme elevations: abnormal hepatic function tests.

Before initiating therapy, consider the following safety measures. - Pregnancy: risk unknown; use only if potential benefit justifies the risk. - Renal function: monitor patients with impaired renal clearance. - Cardiac conduction: obtain baseline ECG in patients with known heart disease. - Concomitant CNS depressants: use with caution to avoid excessive sedation. - Alcohol: avoid excessive consumption as it may enhance CNS effects. - Store at ambient temperature: keep below 25°C, retain in original packaging, and protect from moisture.

Lacosamide can interact with several medicines; review patient medication lists.

Major Interactions (Avoid): - Strong CYP3A4 inducers (e.g., carbamazepine, phenytoin): may markedly reduce lacosamide plasma levels. - Drugs that prolong PR interval (e.g., class I antiarrhythmics): increase risk of cardiac conduction delays. - Other sodium‑channel blockers (e.g., oxcarbazepine): may heighten central nervous system adverse effects.

Moderate Interactions (Monitor Closely): - Antidepressants such as bupropion: can raise lacosamide exposure. - Warfarin: monitor INR as lacosamide may affect anticoagulation control. - Alcohol: may potentiate sedation and dizziness.